BOSTON — As the use of biologic drugs becomes more widespread, optometrists need to be aware of the downstream impacts they could have on patients’ ocular health, according to speakers here.
remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback